Matzim LA

Actavis Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: May 1, 2025
Approval ID: e8c8dd18-9d95-4068-9762-bec1eb1bc25c
Products: 5 registered
Version: 14

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use MATZIM LA (DILTIAZEM HYDROCHLORIDE) EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MATZIM LA (DILTIAZEM HYDROCHLORIDE) EXTENDED-RELEASE TABLETS. Matzim LA (DILTIAZEM HYDROCHLORIDE) extended-release tablets, for oral use

Quick Stats

Total Products5

Labelers2

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.